Reuters logo
BRIEF-Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln
October 13, 2017 / 10:28 AM / a month ago

BRIEF-Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln

Oct 13 (Reuters) - Tandem Diabetes Care Inc:

* Sees Q3 sales about $26.5 million to $27.5 million - sec filing

* Tandem Diabetes - expect seasonality to have similar impact on sales in 2017

* Tandem - ‍do not expect funding from completed or proposed financing to fully address substantial doubt about co’s ability to continue as a going concern​

* Tandem Diabetes-expectation of seasonality impact excludes about $3.5 million deferred sales&upgrade fees received with technology program expected in q3​

* Tandem Diabetes Care Inc- ‍expect we will be required to raise additional capital in order to continue as a going concern​ Source text - bit.ly/2yj5a12 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below